[1]
Al Mukhtar, Z.K. et al. 2018. IMMUNOHISTOCHEMICAL EXPRESSION OF THE PROMISING THERAPEUTIC TARGET (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2/NEU) IN IRAQI PATIENTS WITH MEDULLOBLASTOMA. Asian Journal of Pharmaceutical and Clinical Research. 11, 12 (Dec. 2018), 358–361. DOI:https://doi.org/10.22159/ajpcr.2018.v11i12.28373.